Matthew Chang is Associate Professor at the National University of Singapore and Program Leader of NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI). His research interests lie in synthetic biology of microbial systems, with particular emphasis on development of synthetic microbes that perform programmable functions for engineering applications. In particular, he has pioneered the development of synthetic microbes that show novel programmable therapeutic behaviors. His work has received international recognition and is featured in leading media agencies worldwide. He has been honored with the Scientific and Technological Achievement Award from U.S. Environmental Protection Agency, and serves as an editorial board member for ACS Synthetic Biology and Biotechnology Journal, and as an associate editor for Biotechnology for Biofuels.